Monoclonal Mouse anti‑Human CDH1 / E Cadherin Antibody (clone 813CT11.1.3, WB) LS‑C203946
Monoclonal Mouse anti‑Human CDH1 / E Cadherin Antibody (clone 813CT11.1.3, WB) LS‑C203946
Antibody:
CDH1 / E Cadherin Mouse anti-Human Monoclonal (813CT11.1.3) Antibody
Format:
Unconjugated, Unmodified
Overview
Antibody:
CDH1 / E Cadherin Mouse anti-Human Monoclonal (813CT11.1.3) Antibody
Format:
Unconjugated, Unmodified
Specifications
Description
E Cadherin antibody LS-C203946 is an unconjugated mouse monoclonal antibody to human E Cadherin (CDH1). Validated for WB.
Target
Human CDH1 / E Cadherin
Synonyms
CDH1 | CD324 | CDHE | Cell-CAM 120/80 | E Cadherin | E-Cadherin | ECAD | Epithelial cadherin | Arc-1 | UVO | Cadherin-1 | CAM 120/80 | CD324 antigen | LCAM | Uvomorulin
Reactivity
Human
(tested or 100% immunogen sequence identity)
Clonality
IgG1
Monoclonal
Conjugations
Unconjugated
Presentation
0.09% Sodium Azide
Storage
Short term: store at 4°C. Long term: aliquot and store at -20°C. Avoid freeze-thaw cycles.
Restrictions
For research use only. Intended for use by laboratory professionals.
Guarantee
This antibody carries the LSBio 100% Guarantee.
LSBio Guarantee
Featured Products
Species:
Human
Applications:
IHC, IHC - Frozen, Immunofluorescence, Western blot, Immunoprecipitation, Flow Cytometry, ELISA, Functional Assay
Species:
Mouse, Human
Applications:
IHC, IHC - Paraffin, IHC - Frozen, Immunofluorescence, Western blot, Immunoprecipitation, Flow Cytometry
Species:
Human
Applications:
IHC, IHC - Paraffin, Western blot, ELISA, Proximity Ligation Assay
Species:
Human, Monkey, Mouse, Rat, Dog
Applications:
IHC, IHC - Paraffin, Western blot
Species:
Human
Applications:
IHC, Western blot, Flow Cytometry, ELISA
Species:
Human
Applications:
IHC, IHC - Paraffin, Immunofluorescence, Western blot, Peptide Enzyme-Linked Immunosorbent Assay
Request SDS/MSDS
To request an SDS/MSDS form for this product, please contact our Technical Support department at:
Technical.Support@LSBio.com
Requested From: United States
Date Requested: 9/26/2024